日付 |
時間 |
ソース |
タイトル |
2024/5/10 | 05:05 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
2024/5/10 | 05:01 | EDGAR2 | Form 8-K - Current report |
2024/5/10 | 05:01 | PRNUS | Co-Diagnostics, Inc. Reports First Quarter 2024 Financial.. |
2024/4/25 | 22:30 | PRNUS | Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings.. |
2024/4/24 | 22:30 | PRNUS | Co-Diagnostics, Inc. to Host Booth and Deliver Presentation.. |
2024/4/12 | 22:30 | PRNUS | Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility.. |
2024/4/04 | 22:30 | PRNUS | Co-Diagnostics, Inc. Appoints New President and Other.. |
2024/3/21 | 22:30 | PRNUS | Co-Diagnostics, Inc. CEO Delivers Manufacturing and.. |
2024/3/18 | 22:30 | PRNUS | Co-Diagnostics, Inc. CEO to Deliver Keynote Address at.. |
2024/3/15 | 05:01 | PRNUS | Co-Diagnostics, Inc. Reports Full Year 2023 Financial.. |
2024/3/07 | 23:30 | PRNUS | Co-Diagnostics, Inc. JV CoSara Receives Clearance from.. |
2024/2/29 | 23:30 | PRNUS | Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year.. |
2024/2/01 | 23:30 | PRNUS | Co-Diagnostics, Inc. Shares List of Upcoming Industry.. |
2024/1/03 | 23:30 | PRNUS | Co-Diagnostics, Inc. to Host Booth at CES 2024 January 9-12 |
2023/12/27 | 23:30 | PRNUS | Co-Diagnostics, Inc. Completes Submission to FDA for Co-Dx.. |
2023/11/29 | 23:30 | PRNUS | Co-Diagnostics, Inc. to Participate in the Piper Sandler.. |
2023/11/28 | 06:50 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2023/11/28 | 06:38 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2023/11/28 | 06:37 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2023/11/10 | 06:05 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
2023/11/10 | 06:01 | EDGAR2 | Form 8-K - Current report |
2023/11/10 | 06:01 | PRNUS | Co-Diagnostics, Inc. Reports Third Quarter 2023 Financial.. |
2023/11/02 | 22:30 | PRNUS | Co-Diagnostics, Inc. Announces Additional Grant Award for.. |
2023/10/31 | 22:30 | PRNUS | Co-Diagnostics, Inc. Shares List of Upcoming Industry.. |
2023/10/26 | 22:30 | PRNUS | Co-Diagnostics, Inc. Announces Third Quarter 2023 Earnings.. |
2023/10/23 | 22:30 | PRNUS | Co-Diagnostics, Inc. to Host Booth at CASMET Symposium.. |
2023/10/16 | 22:30 | PRNUS | Co-Diagnostics, Inc. to Host Booth at Medlab Africa 2023 in.. |
2023/9/27 | 22:30 | PRNUS | Co-Diagnostics, Inc. to Participate in the 2023 UHCA/UCAL.. |
2023/9/22 | 22:30 | PRNUS | Co-Diagnostics, Inc. to Participate in 6th ACTC Conference.. |
2023/9/21 | 22:30 | PRNUS | Co-Diagnostics, Inc. to Participate in Gilmartin Group.. |
2023/9/07 | 22:30 | PRNUS | Co-Diagnostics, Inc. to Participate in the H.C. Wainwright.. |
2023/9/01 | 05:05 | EDGAR2 | Form 8-K - Current report |
2023/8/29 | 22:30 | PRNUS | Co-Diagnostics, Inc. Appoints Chief Regulatory Affairs.. |
2023/8/18 | 22:30 | PRNUS | Co-Diagnostics, Inc. to Present at 15th Next Generation Dx.. |
2023/8/17 | 00:30 | PRNUS | Co-Diagnostics, Inc. to Host Booth at Medlab Asia Conference.. |
2023/8/11 | 05:05 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
2023/8/11 | 05:03 | EDGAR2 | Form 8-K - Current report |
2023/8/11 | 05:01 | PRNUS | Co-Diagnostics, Inc. Reports Second Quarter 2023 Financial.. |
2023/7/27 | 22:30 | PRNUS | Co-Diagnostics, Inc. Announces Second Quarter 2023 Earnings.. |
2023/7/20 | 22:30 | PRNUS | Co-Diagnostics, Inc. to Host Booth and Discuss Recent Grant.. |
2023/7/20 | 19:10 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
2023/7/18 | 22:30 | PRNUS | Co-Diagnostics, Inc. Announces Recent Grant Awards |
2023/7/13 | 22:30 | PRNUS | Co-Diagnostics, Inc. Awarded Funding for Co-Dx PCR Home.. |